Ray continued, “We’re also delighted to acknowledge Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology ended up instrumental to shaping the event of STK-012, our 1st-in-class alpha/beta biased IL-2. Its unique system expands the therapeutic index of IL-two, one among https://httpswwwzosanopharmacomte00876.pages10.com/https-www-zosanopharma-com-technology-can-be-fun-for-anyone-71951247